Athersys Licenses its Animal Health Assets to Ardent Animal Health

CLEVELAND & LEXINGTON, Ky.--(BUSINESS WIRE)--Athersys, Inc. (Nasdaq: ATHX), a cell therapy and regenerative medicine company developing MultiStem® (invimestrocel) for critical care indications, and Multipotent Adult Progenitor Cell (MAPC®) technology for equine, canine, and feline health applications, announces the...

Related Keywords

Texas ,United States ,Kentucky ,Tirtht Patel ,Thomas Masterson ,Dan Camardo ,Ellen Gurley ,Ardent Animal Health ,Corporate Communications ,Nasdaq ,Facebook ,Twitter ,Athersys Inc ,Linkedin ,Multipotent Adult Progenitor Cell ,Athersy Multipotent Adult Progenitor Cell ,Secure Integrated Freezer Unit ,Chief Executive Officer ,Animal Health ,Breakthru Portfolio ,Private Securities Litigation Reform Act ,Texas Health Science Center ,Athersy Annual Report ,Investor Relations ,